Clinical Trial Update: Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating whether zoledronic acid can prevent bone metastasis in patients with stage IIIB or IV lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Zoledronic acid (Zometa) (zoledronic acid)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Lung Cancer | Phase 3 | Status: UNKNOWN